Aberdeen Group’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.95M | Hold |
279,828
| – | – | 0.01% | 648 |
|
|
2025
Q1 | $8.26M | Buy |
279,828
+234,916
| +523% | +$6.93M | 0.02% | 610 |
|
|
2024
Q4 | $1.31M | Buy |
44,912
+20,076
| +81% | +$584K | ﹤0.01% | 801 |
|
|
2024
Q3 | $1.14M | Sell |
24,836
-10,802
| -30% | -$496K | ﹤0.01% | 802 |
|
|
2024
Q2 | $1.46M | Sell |
35,638
-93,776
| -72% | -$3.83M | ﹤0.01% | 788 |
|
|
2024
Q1 | $3.3M | Hold |
129,414
| – | – | 0.01% | 729 |
|
|
2023
Q4 | $1.17M | Buy |
+129,414
| New | +$1.17M | ﹤0.01% | 823 |
|